Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Immunalysis Tapentadol Urine HEIA

K-Number: K203527 · 2022-05-09

Decision Date2022-05-09
Product CodeDJG
Advisory CommitteeTX
DecisionSubstantially Equivalent

Device Summary

Immunalysis Tapentadol Urine HEIA is the device name listed in this FDA 510(k) record. The listed applicant is Lmmunalysis Corporation. It received FDA 510(k) clearance on 2022-05-09 under 510(k) number K203527. The device is classified under product code DJG. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Immunalysis Tapentadol Urine HEIA?

Immunalysis Tapentadol Urine HEIA is a medical device that received FDA 510(k) clearance on 2022-05-09. The listed applicant is Lmmunalysis Corporation. The 510(k) number is K203527.

When did Immunalysis Tapentadol Urine HEIA receive FDA 510(k) clearance?

Immunalysis Tapentadol Urine HEIA received FDA 510(k) clearance on 2022-05-09, under 510(k) number K203527.

Who is the listed applicant for Immunalysis Tapentadol Urine HEIA?

The FDA 510(k) record lists Lmmunalysis Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Immunalysis Tapentadol Urine HEIA?

The FDA product code for Immunalysis Tapentadol Urine HEIA is DJG.

Related Devices (Code: DJG)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.